Increasing survival of metastatic breast cancer through locoregional surgery.

CONCLUSIONS: Our cohort supports that locoregional treatment in selected patients with de novo metastatic breast cancer significantly improved survival, so it might be considered in combination with systemic therapy. PMID: 28994557 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28994557?dopt=Abstract

Source: Minerva Ginecologica - October 11, 2017 Category: OBGYN Tags: Minerva Ginecol Source Type: research